Keros Therapeutics, Inc. (KROS)
19.26
+0.24
(+1.26%)
USD |
NASDAQ |
Jan 22, 13:53
Keros Therapeutics Cash from Investing (Quarterly): -0.132M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -1.299M |
| MannKind Corp. | -25.06M |
| Insmed, Inc. | -762.23M |
| Innoviva, Inc. | 18.41M |
| CorMedix, Inc. | -291.32M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.249M |
| Cash from Financing (Quarterly) | 0.14M |
| Free Cash Flow | 87.08M |
| Free Cash Flow Per Share (Quarterly) | 0.0767 |
| Free Cash Flow to Equity (Quarterly) | 3.642M |
| Free Cash Flow to Firm (Quarterly) | 3.117M |
| Free Cash Flow Yield | 11.12% |